The CD28/HLA-DR expressions on CD4+ T but not CD8+ T cells are significant predictors for progression to AIDS

被引:19
作者
Choi, BS
Park, YK
Lee, JS
机构
[1] Korea Univ, Natl Inst Hlth, Ctr AIDS Res, Dept Virol, Seoul 122701, South Korea
[2] Korea Univ, Grad Sch Biotechnol, Seoul 122701, South Korea
关键词
HIV; CD4; level; HLA-DR molecule; CD28; molecule; disease progression;
D O I
10.1046/j.1365-2249.2002.01732.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the changes of CD28 and HLA-DR molecules on CD4(+) and CD8(+) T cells during HIV infection, we classified 130 HIV-infected Koreans into four groups by the CD4 level as follows: group I (greater than or equal to500 cells/mm(3) ), group II (201-499 cells/mm(3) ), group III (51-200 cells/mm(3) ), and group IV (less than or equal to50 cells/mm(3) ). In CD4(+) T cells, the proportion of CD28 expression decreased significantly with the CD4 level while the proportion of HLA-DR expression increased gradually. In particular, the changes of HLA-DR expressions on CD4(+) T cells were parallel to the loss of CD28 molecules from stage III to IV. However, the CD28 expression on CD8(+) T cells decreased dramatically in the early stage of HIV infection, and the sum and pattern of CD28 and HLA-DR expressions on CD8(+) T cells was stable after the first stage. Even though CD28 down-regulation on CD8(+) T cells was very severe from the early stage of HIV infection, it might not influence the survival time of HIV-infected Koreans. The sum of the CD28(+) subsets and HLA-DR subsets in each T cell was stable in all stages of disease progression. The sums of the CD28(+) subsets and HLA-DR+ subsets in CD4(+) T and CD8(+) T cells were constant as approximately 100% and 55-60% of each T cell. These results suggested that the changes of CD28/HLA-DR expressions on CD4(+) T cells were more predictable than those on CD8(+) T cells in the evaluation of the disease progression during HIV-infected periods. However, we need further studies to understand why the sum of two molecules in each T cell are constant.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 50 条
  • [31] CD4+/CD8+ double-positive T cells: more than just a developmental stage?
    Overgaard, Nana H.
    Jung, Ji-Won
    Steptoe, Raymond J.
    Wells, James W.
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 97 (01) : 31 - 38
  • [32] Phenotype and Functionality of CD4+ and CD8+ T Cells in the Upper Reproductive Tract of Healthy Premenopausal Women
    Shanmugasundaram, Uma
    Critchfield, J. William
    Pannell, Jane
    Perry, Jean
    Giudice, Linda C.
    Smith-McCune, Karen
    Greenblatt, Ruth M.
    Shacklett, Barbara L.
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2014, 71 (02) : 95 - 108
  • [33] HIV-1 adapts to HLA class II-associated selection pressure exerted by CD4+ and CD8+ T cells
    Alves, Eric
    Currenti, Jennifer
    Crawford, Keeley
    Chopra, Abha
    Ram, Ramesh
    Barnett, Louise
    Read, James F.
    Al-kaabi, Marwah
    James, Ian
    Carlson, Jonathan M.
    Eton, Max
    Stelmach, Sophie
    Deshpande, Pooja
    Pilkinton, Mark A.
    Mcdonnell, Wyatt J.
    Bosco, Anthony
    Mallal, Simon A.
    John, Mina
    Kalams, Spyros A.
    Gaudieri, Silvana
    [J]. SCIENCE ADVANCES, 2025, 11 (07):
  • [34] Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset
    Nishanian, P
    Taylor, JMG
    Manna, B
    Aziz, N
    Grosser, S
    Giorgi, JV
    Detels, R
    Fahey, JL
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 (02): : 162 - 170
  • [35] Ovalbumin lipid core peptide vaccines and their CD4+ and CD8+ T cell responses
    Simerska, Pavia
    Suksamran, Tittaya
    Ziora, Zyta Maria
    Rivera, Fabian de Labastida
    Engwerda, Christian
    Toth, Istvan
    [J]. VACCINE, 2014, 32 (37) : 4743 - 4750
  • [36] Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4+ T cells to HIV-infected persons
    Bernstein, WB
    Cox, JH
    Aronson, NE
    Tracy, LR
    Schlienger, K
    Ratto-Kim, S
    Garner, R
    Cotte, J
    Zheng, ZH
    Winestone, L
    Liebig, C
    Galley, LM
    Connors, M
    Birx, DL
    Carroll, RG
    Levine, BL
    [J]. CLINICAL IMMUNOLOGY, 2004, 111 (03) : 262 - 274
  • [37] Dominant Enrichment of Phenotypically Activated CD38+HLA-DR+CD8+ T Cells, Rather Than CD38+HLA-DR+CD4+ T Cells, in HIV/HCV Coinfected Patients on Antiretroviral Therapy
    d'Ettorre, Gabriella
    Ceccarelli, Giancarlo
    Serafino, Sara
    Giustini, Noemi
    Cavallari, Eugenio Nelson
    Bianchi, Luigi
    Pavone, Paolo
    Bellelli, Valeria
    Turriziani, Ombretta
    Antonelli, Guido
    Stroffolini, Tommaso
    Vullo, Vincenzo
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (08) : 1347 - 1356
  • [38] Circulating CD4+ TEMRA and CD4+ CD28- T cells and incident diabetes among persons with and without HIV
    Bailin, Samuel S.
    Kundu, Suman
    Wellons, Melissa
    Freiberg, Matthew S.
    Doyle, Margaret F.
    Tracy, Russell P.
    Justice, Amy C.
    Wanjalla, Celestine N.
    Landay, Alan L.
    So-Armah, Kaku
    Mallal, Simon
    Kropski, Jonathan A.
    Koethe, John R.
    [J]. AIDS, 2022, 36 (04) : 501 - 511
  • [39] CD4+ T-Lymphocyte Count/CD8+ T-Lymphocyte Count Ratio: Surrogate for HIV Infection in Infants?
    Navaneethapandian, Poorana Ganga Devi
    Karunaianantham, Ramesh
    Subramanyan, Sudha
    Chinnayan, Ponnuraja
    Chandrasekaran, Padmapriyadarsini
    Swaminathan, Soumya
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 2012, 58 (05) : 394 - 397
  • [40] CD4+ and CD8+ T-lymphocyte scores cannot reliably predict progression in patients with benign prostatic hyperplasia
    Lamb, Alastair D.
    Qadan, Motaz
    Roberts, Simon
    Timlin, Hannah
    Vowler, Sarah L.
    Campbell, Fiona M.
    Grigor, Ken
    Bartlett, John M. S.
    McNeill, S. Alan
    [J]. BJU INTERNATIONAL, 2011, 108 (2B) : E43 - E50